TY - JOUR
T1 - Standardized image interpretation and post processing in cardiovascular magnetic resonance
T2 - Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing
AU - Schulz-Menger, Jeanette
AU - Bluemke, David A.
AU - Bremerich, Jens
AU - Flamm, Scott D.
AU - Fogel, Mark A.
AU - Friedrich, Matthias G.
AU - Kim, Raymond J.
AU - Von Knobelsdorff-Brenkenhoff, Florian
AU - Kramer, Christopher M.
AU - Pennell, Dudley J.
AU - Plein, Sven
AU - Nagel, Eike
N1 - Funding Information:
Jeanette Schulz-Menger: Institutional research support from Siemens Healthcare ,Circle Cardiovascular Imaging Inc and Medis. Consultant for Bayer Healthcare. Christopher M. Kramer: Dr. Kramer acknowledges research support from Siemens Healthcare Florian von Knobelsdorff-Brenkenhoff: Dr. von Knobelsdorff-Brenkenhoff acknowledges research support from the Else Kröner-Fresenius-Stiftung, Germany Scott D. Flamm: Dr. Flamm acknowledges institutional grant/research support from Siemens Medical Solutions and Philips Healthcare, and acts as a Consultant/Advisory Board Member for Bayer Healthcare and Circle Cardiovascular, Inc. Scott D. Flamm: Consultant for Bayer Healthcare. Institutional research support from Siemens Healthcare and Philips Healthcare. David A. Bluemke: --- Sven Plein: Dr. Plein acknowledges research support from Philips Healthcare Raymond J. Kim: 1) Dr. RJ Kim is an inventor on a United States patent, owned by Northwestern University, concerning the use of contrast-enhanced MRI to detect myocardial viability. 2) Dr. RJ Kim has an education grant from Siemens Medical Solutions. 3) Dr. RJ Kim is a co-founder of HeartIT, LLC Matthias G. Friedrich: Dr. Friedrich is partially funded by the Canadian Foundation for Innovation and the Fonds de Recherche Santé Québec Matthias G. Friedrich: Matthias G. Friedrich is on the board of directors and shareholder of Circle Cardiovascular Imaging Inc., the manufacturer of a CMR-post processing and evaluation software Dudley J. Pennell: This work was supported by the NIHR Cardiovascular Biomedical Research Unit of Royal Brompton & Harefield NHS Foundation Trust and Imperial College. Dudley J. Pennell: Consultant Siemens, Apotex Novartis. Director and stockholder, Cardiovascular Imaging Solutions. Mark A. Fogel: Two NIH RO1 grants, grant from Siemens to develop functional fetal cardiac MR, grant from Edwards Life Sciences - CMR Core lab for COMPASSION trial and Kereos - Medical Monitor for P19 imaging agent. Jens Bremerich: --- Eike Nagel: Dr. Nagel acknowledges financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College Hospital NHS Foundation Trust; the Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC under grant number WT 088641/Z/09/Z; Funded by the British Heart Foundation award RE/08/ 003. Grant support from Philips HealthcareGrant support from Bayer Healthcare. * Endorsed by the board of trustees of the Society for Cardiovascular Magnetic Resonance: Andrew Arai, MD ; Albert de Roos ; Orlando Simonetti, PhD; Victor A. Ferrari, MD ; Scott D. Flamm, MD, MBA ; David A. Bluemke, MD, PhD; Jens Bremerich, MD; Ralph Gentry, RT, R, MR, CT ; Frederick H. Epstein, PhD; Raymond Kwong, MD; Edward T. Martin, MD; Dudley J. Pennell, MD; Sven Plein, MD, PhD; Andrew J. Powell, MD; Jeanette Schulz-Menger, MD; Joseph Selvanayagam, MBBS, FRACP; Matthias Stuber, PhD.
PY - 2013
Y1 - 2013
N2 - With mounting data on its accuracy and prognostic value, cardiovascular magnetic resonance (CMR) is becoming an increasingly important diagnostic tool with growing utility in clinical routine. Given its versatility and wide range of quantitative parameters, however, agreement on specific standards for the interpretation and post-processing of CMR studies is required to ensure consistent quality and reproducibility of CMR reports. This document addresses this need by providing consensus recommendations developed by the Task Force for Post Processing of the Society for Cardiovascular MR (SCMR). The aim of the task force is to recommend requirements and standards for image interpretation and post processing enabling qualitative and quantitative evaluation of CMR images. Furthermore, pitfalls of CMR image analysis are discussed where appropriate.
AB - With mounting data on its accuracy and prognostic value, cardiovascular magnetic resonance (CMR) is becoming an increasingly important diagnostic tool with growing utility in clinical routine. Given its versatility and wide range of quantitative parameters, however, agreement on specific standards for the interpretation and post-processing of CMR studies is required to ensure consistent quality and reproducibility of CMR reports. This document addresses this need by providing consensus recommendations developed by the Task Force for Post Processing of the Society for Cardiovascular MR (SCMR). The aim of the task force is to recommend requirements and standards for image interpretation and post processing enabling qualitative and quantitative evaluation of CMR images. Furthermore, pitfalls of CMR image analysis are discussed where appropriate.
KW - Heart
KW - Image interpretation
KW - Magnetic resonance imaging
KW - Post processing
KW - Recommendations
UR - http://www.scopus.com/inward/record.url?scp=84876805792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876805792&partnerID=8YFLogxK
U2 - 10.1186/1532-429X-15-35
DO - 10.1186/1532-429X-15-35
M3 - Article
C2 - 23634753
AN - SCOPUS:84876805792
SN - 1097-6647
VL - 15
JO - Journal of Cardiovascular Magnetic Resonance
JF - Journal of Cardiovascular Magnetic Resonance
IS - 1
M1 - 35
ER -